Clinical trials recruiting for Large Cell Neuroendocrine Carcinoma of the Lung
3
Recruiting trials
5
US states with sites
5
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 111In-ETN029 | 1 |
| 225Ac-ETN029 | 1 |
| Concurrent Radiation Therapy | 1 |
| Durvalumab with etoposide and Carboplatin/Cisplatin | 1 |
| Sequential Radiation therapy | 1 |
| Tarlatamab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Washington | 2 |
| Arizona | 1 |
| Iowa | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
Top cities
Self-screener
Recruiting trials
- FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
- Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Related conditions
Trials recruiting for Large Cell Neuroendocrine Carcinoma of the Lung often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Merkel Cell Carcinoma 12Testicular Cancer 11Small Cell Lung Carcinoma 20Prostate cancer 1234Non-small cell lung cancer 507Melanoma 487Medullary Thyroid Cancer 3Cervical cancer 71Bladder cancer 59
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Large Cell Neuroendocrine Carcinoma of the Lung trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.